Shares of OptiBiotix Health Plc (LON:OPTI – Get Free Report) traded down 2.6% during trading on Tuesday . The company traded as low as GBX 18.50 ($0.23) and last traded at GBX 18.75 ($0.23). 91,261 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 248,946 shares. The stock had previously closed at GBX 19.25 ($0.24).
OptiBiotix Health Price Performance
The company has a debt-to-equity ratio of 4.51, a current ratio of 3.59 and a quick ratio of 7.89. The business’s 50 day moving average price is GBX 22.75 and its 200 day moving average price is GBX 25.55. The stock has a market capitalization of £16.41 million, a P/E ratio of -120.00 and a beta of 1.62.
OptiBiotix Health Company Profile
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
Featured Articles
- Five stocks we like better than OptiBiotix Health
- The 3 Best Fintech Stocks to Buy Now
- Comprehensive PepsiCo Stock Analysis
- Ride Out The Recession With These Dividend Kings
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is Put Option Volume?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.